Published in Nephron on January 01, 1983
Occupational and other exposures associated with male end-stage renal disease: a case/control study. Am J Public Health (1990) 2.26
Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. Br Med J (Clin Res Ed) (1986) 1.65
Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepatic and renal disorders. BMC Complement Altern Med (2006) 1.43
Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney. BMC Pharmacol (2005) 1.24
Possibilities of detecting health effects by studies of populations exposed to chemicals from waste disposal sites. Environ Health Perspect (1985) 1.17
Renal disease and occupational exposure to organic solvents: a case referent approach. Br J Ind Med (1989) 1.12
Membranous glomerulonephritis. J Clin Pathol (1986) 0.98
Hazard evaluation of chemicals that cause accumulation of alpha 2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats. Environ Health Perspect (1993) 0.90
Binding of anti-basement membrane antibody to alveolar basement membrane after intratracheal gasoline instillation in rabbits. Am J Pathol (1987) 0.88
Chronic glomerulonephritis and exposure to solvents: a case-referent study. Br J Ind Med (1992) 0.84
Nephrotoxicity of organic solvents: biomarkers for early detection. Int Arch Occup Environ Health (2005) 0.76
Identification of Goodpasture antigens in human alveolar basement membrane. Clin Exp Immunol (1988) 0.75
The hepatoprotective activity of olive oil and Nigella sativa oil against CCl4 induced hepatotoxicity in male rats. BMC Complement Altern Med (2016) 0.75
IgA nephropathy in a laboratory worker that progressed to end-stage renal disease: a case report. Ann Occup Environ Med (2016) 0.75
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med (2001) 11.48
Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development (2001) 4.13
A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat Neurosci (2001) 3.56
Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol (2001) 3.26
The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem (1987) 2.64
Live astrocytes visualized by green fluorescent protein in transgenic mice. Dev Biol (1997) 2.64
Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int (1997) 2.54
Single synaptic events evoke NMDA receptor-mediated release of calcium from internal stores in hippocampal dendritic spines. Neuron (1999) 2.37
Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol (2008) 2.30
Calcium stores in hippocampal synaptic boutons mediate short-term plasticity, store-operated Ca2+ entry, and spontaneous transmitter release. Neuron (2001) 2.26
The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.26
Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: data for genetic counselling. Am J Med Genet (1984) 2.10
Extracellular Ca2+ depletion contributes to fast activity-dependent modulation of synaptic transmission in the brain. Neuron (2003) 2.01
Syndrome associated with the abuse of analgesics. Ann Intern Med (1968) 1.82
Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J Neurosci (2001) 1.73
A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney Int (1995) 1.68
Predicting glomerular function from adjusted serum creatinine. Nephron (1992) 1.64
Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clin Invest Med (1995) 1.63
Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol (2000) 1.62
Quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology (1991) 1.57
Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med (1987) 1.53
Genetic linkage of autosomal dominant juvenile glaucoma to 1q21-q31 in three affected pedigrees. Genomics (1994) 1.50
Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis (2000) 1.49
The natural history of asymptomatic urolithiasis. J Urol (1992) 1.49
Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int (2000) 1.48
Potential therapeutic initiatives for fibrogenic lung diseases. Chest (1995) 1.46
Drinking water hardness and urolithiasis. Ann Intern Med (1978) 1.45
Interstitial nephritis in patients with inflammatory bowel disease treated with mesalamine. J Clin Gastroenterol (2001) 1.44
The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis (2000) 1.43
Calcium antagonists and acute renal failure. Am J Med (1989) 1.43
Informed consent in California. Latent liability without 'negligence'. West J Med (1977) 1.39
Fluorescence monitoring of electrical responses from small neurons and their processes. Biophys J (1983) 1.39
Repeated confocal imaging of individual dendritic spines in the living hippocampal slice: evidence for changes in length and orientation associated with chemically induced LTP. J Neurosci (1995) 1.35
Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int (1984) 1.33
Sleep complaints are common in a dialysis unit. Am J Kidney Dis (1995) 1.29
Clinical practice guidelines for initiation of dialysis. Canadian Society of Nephrology. J Am Soc Nephrol (1999) 1.26
Loss of adenylyl cyclase I activity disrupts patterning of mouse somatosensory cortex. Nat Genet (1998) 1.25
Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int (2000) 1.24
Fibrotic reactions in the lung: the activation of the lung fibroblast. Exp Lung Res (1986) 1.22
Long-term potentiation in the rat dentate gyrus is associated with enhanced Arc/Arg3.1 protein expression in spines, dendrites and glia. Eur J Neurosci (2005) 1.22
Clinimetrics in nephrology. Nephron (1986) 1.18
Peritoneal membrane transport and hypoalbuminemia: cause or effect? Perit Dial Int (2000) 1.18
Potentially lethal interaction of cimetidine and morphine. Can Med Assoc J (1981) 1.16
Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis (1997) 1.13
Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. Endocrinology (1989) 1.13
To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy. CMAJ (2000) 1.13
Programmed cell death contributes to postnatal lung development. Am J Respir Cell Mol Biol (1998) 1.10
Furosemide kinetics in renal failure. Clin Pharmacol Ther (1978) 1.10
Transforming-growth-factor-beta activation elements in the distal promoter regions of the rat alpha 1 type I collagen gene. Biochem J (1991) 1.09
Confocal microscopy: applications in neurobiology. Trends Neurosci (1988) 1.08
Solute clearance approach to adequacy of peritoneal dialysis. Perit Dial Int (1997) 1.08
The quality of life in renal transplantation--a prospective study. Transplantation (1992) 1.08
Regulation of the alpha 1(I) collagen promoter via a transforming growth factor-beta activation element. J Biol Chem (1993) 1.06
A multicenter study of noncompliance with continuous ambulatory peritoneal dialysis exchanges in US and Canadian patients. Am J Kidney Dis (2000) 1.05
Derivation of lung epithelium from bone marrow cells. Cytotherapy (2003) 1.04
Albumin-corrected calcium and ionized calcium in stable haemodialysis patients. Nephrol Dial Transplant (2000) 1.03
Long-term follow-up of bronchiectasis. J Lancet (1966) 1.03
Cadaver kidney transplants. Transplantation (1967) 1.02
Analgesic nephropathy. A clinicopathologic study using electron microscopy. Am J Med (1971) 1.02
Urolithiasis complicating inflammatory bowel disease. J Urol (1992) 1.02
Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease. Brain Res (1986) 1.01
Improvements in drug prescription labels for patients with limited education or vision. Can Med Assoc J (1982) 1.01
Analgesic habits of 500 veterans: incidence and complications of abuse. Can Med Assoc J (1968) 1.01
Impact of sodium and ultrafiltration profiling on hemodialysis-related symptoms. J Am Soc Nephrol (2001) 1.00
Changes of blood pressure, renin, and angiotensin after bilateral nephrectomy in patients with chronic renal failure. Br Med J (1972) 0.99
Determination of acetylator status in uraemia. Br J Clin Pharmacol (1975) 0.99
Postsynaptic calcium transients evoked by activation of individual hippocampal mossy fiber synapses. J Neurosci (2001) 0.99
In vitro propagation and inducible differentiation of multipotential progenitor cells from human fetal brain. Neuroscience (1997) 0.98
Cerebral and pontine myelinolysis. Two cases with fluid and electrolyte imbalance and hypotension. J Neurol Sci (1973) 0.98
Canadian survey of clinical status at dialysis initiation 1998-1999: a multicenter prospective survey. Clin Nephrol (2002) 0.98
Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int (2000) 0.97
Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice. Clin Transplant (2013) 0.97
Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-beta receptor: regulation by TGF-beta. Biochim Biophys Acta (1996) 0.96
Hypernatremia, azotemia, and dehydration ue to high-protein tube feeding. Ann Intern Med (1968) 0.95
Renal disease-a sixth cardinal feature of the Laurence-Moon-Biedl syndrome. Clin Nephrol (1981) 0.95
Medical treatment to prevent recurrent calcium urolithiasis. A guide to critical appraisal. Miner Electrolyte Metab (1987) 0.94
Airway epithelial Fas ligand expression: potential role in modulating bronchial inflammation. Am J Physiol (1998) 0.94
Glomerular injury in patients with neoplasia. Annu Rev Med (1976) 0.93
TRAIL expression in vascular smooth muscle. Am J Physiol Lung Cell Mol Physiol (2000) 0.93
Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J Immunol (1998) 0.93
Although illusive, quality continues to be a vital measure for MCOs and employers. Exec Solut Healthc Manag (1999) 0.92
The origin of neuronal polarization: a model of axon formation. Philos Trans R Soc Lond B Biol Sci (1996) 0.92
Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease. Nephrol Dial Transplant (2001) 0.92
Hydrolysis of digoxin by acid. J Pharm Pharmacol (1977) 0.91
How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Kidney Int Suppl (1996) 0.90
Left ventricular hypertrophy in end-stage renal disease. Nephron (1988) 0.90
Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee. Pediatrics (1999) 0.89
The use of ultrasound to study the prevalence of hydatid cysts in the right lung and liver of sheep and goats in Turkana, Kenya. Int J Parasitol (1996) 0.89
FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3. Eur J Immunol (1999) 0.89
Development of SLE among "potential SLE" patients seen in consultation: long-term follow-up. Int J Clin Pract (2014) 0.89
Perineuronal nets in the rhesus monkey and human basal forebrain including basal ganglia. Neuroscience (2001) 0.89
Patients on chronic peritoneal dialysis for ten years or more in North America. Perit Dial Int (2000) 0.89
Persistence of individual dendritic spines in living brain slices. Neuroreport (1992) 0.88
Clinical features and severity of nonspecific symptoms in dialysis patients. Nephron (1988) 0.88
Kidney transplantation and long-term dialysis. Am Heart J (1970) 0.88